Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Cryoglobulinemia vasculitis: an update.

Terrier B, Cacoub P.

Curr Opin Rheumatol. 2013 Jan;25(1):10-8. doi: 10.1097/BOR.0b013e32835b15f7. Review.

PMID:
23196322
2.

Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach.

Perez-Alamino R, Espinoza LR.

Curr Rheumatol Rep. 2014 May;16(5):420. doi: 10.1007/s11926-014-0420-0. Review.

PMID:
24647999
3.

Cryoglobulinemia Vasculitis.

Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D.

Am J Med. 2015 Sep;128(9):950-5. doi: 10.1016/j.amjmed.2015.02.017. Epub 2015 Mar 30. Review.

PMID:
25837517
4.

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.

Terrier B, Launay D, Kaplanski G, Hot A, Larroche C, Cathébras P, Combe B, de Jaureguiberry JP, Meyer O, Schaeverbeke T, Somogyi A, Tricot L, Zénone T, Ravaud P, Gottenberg JE, Mariette X, Cacoub P.

Arthritis Care Res (Hoboken). 2010 Dec;62(12):1787-95. doi: 10.1002/acr.20318.

5.

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.

Terrier B, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, de Saint-Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Diot E, Lazaro E, Bridoux F, Zénone T, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

Blood. 2012 Jun 21;119(25):5996-6004. doi: 10.1182/blood-2011-12-396028. Epub 2012 Apr 3.

6.

Cold hard facts of cryoglobulinemia: updates on clinical features and treatment advances.

Ghetie D, Mehraban N, Sibley CH.

Rheum Dis Clin North Am. 2015;41(1):93-108, viii-ix. doi: 10.1016/j.rdc.2014.09.008. Review.

PMID:
25399942
7.

Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.

Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, Graffin B, Hot A, Kahn JE, Michel C, Quemeneur T, de Saint-Martin L, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

J Autoimmun. 2015 Dec;65:74-81. doi: 10.1016/j.jaut.2015.08.008. Epub 2015 Aug 29. Review.

PMID:
26320984
8.

The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.

Terrier B, Karras A, Kahn JE, Le Guenno G, Marie I, Benarous L, Lacraz A, Diot E, Hermine O, de Saint-Martin L, Cathébras P, Leblond V, Modiano P, Léger JM, Mariette X, Senet P, Plaisier E, Saadoun D, Cacoub P.

Medicine (Baltimore). 2013 Mar;92(2):61-8. doi: 10.1097/MD.0b013e318288925c.

9.
10.

Improvement in psoriasis during rituximab therapy for mixed cryoglobulinemia type II.

Moberg P, Charles JF, Respicio G, Venna SS, Rooney T.

Cutis. 2010 Sep;86(3):133-5.

PMID:
21049729
11.

Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.

Saadoun D, Delluc A, Piette JC, Cacoub P.

Curr Opin Rheumatol. 2008 Jan;20(1):23-8. doi: 10.1097/BOR.0b013e3282f1330c. Review.

PMID:
18281853
12.

Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis.

Terrier B, Karras A, Cluzel P, Collet JP, Sène D, Saadoun D, Cacoub P.

Am J Cardiol. 2013 Jan 15;111(2):265-72. doi: 10.1016/j.amjcard.2012.09.028. Epub 2012 Oct 30.

PMID:
23116612
13.

Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey.

Terrier B, Carrat F, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, de Saint Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Hummel A, Diot E, Pagnoux C, Lzaro E, Bridoux F, Zenone T, Hermine O, Leger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

Ann Rheum Dis. 2013 Mar;72(3):374-80. doi: 10.1136/annrheumdis-2012-201405. Epub 2012 May 14.

PMID:
22586172
14.

Health-related quality of life in severe cryoglobulinaemic vasculitis and improvement after B-cell depleting therapy.

Quartuccio L, Isola M, Masolini P, Scaini P, Zani R, Tavoni A, Pietrogrande M, Bombardieri S, De Vita S.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S9-14. Epub 2012 Oct 3.

PMID:
23044040
15.

[Hepatitis associated cryoglobulinemia].

Pischke S, Cornberg M, Manns MP.

Internist (Berl). 2008 Mar;49(3):297-304. doi: 10.1007/s00108-007-2014-7. Review. German.

PMID:
18327517
16.

Cryoglobulinemic vasculitis.

Ferri C, Mascia MT.

Curr Opin Rheumatol. 2006 Jan;18(1):54-63. Review.

PMID:
16344620
17.

Infections in vasculitis.

Guillevin L.

Best Pract Res Clin Rheumatol. 2013 Feb;27(1):19-31. doi: 10.1016/j.berh.2013.01.004. Review.

PMID:
23507054
18.

Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.

Fabrizi F, Plaisier E, Saadoun D, Martin P, Messa P, Cacoub P.

Am J Kidney Dis. 2013 Apr;61(4):623-37. doi: 10.1053/j.ajkd.2012.08.040. Epub 2012 Oct 25. Review.

PMID:
23102733
19.

Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.

Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, Tavoni A, Zignego AL, De Vita S.

Autoimmun Rev. 2011 Nov;11(1):48-55. doi: 10.1016/j.autrev.2011.07.005. Epub 2011 Jul 24. Review.

20.

Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis.

Lo KY, Chen CY, Lee CS.

Ren Fail. 2009;31(2):149-52. doi: 10.1080/08860220802595906.

PMID:
19212913

Supplemental Content

Support Center